GL-0817

· Gliknik Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GL-0817, covering 2022-03-08 to 2022-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity [Phase 2]

See pricing